This contract expires in 110 days (Sep 30, 2026).
PROMEGA CORPORATION - GENEPRINT(R) 24 SYSTEM, 400RXN KITS FOR PATIENT CARE TESTING.
Key Details
Description
GENEPRINT(R) 24 SYSTEM, 400RXN KITS FOR PATIENT CARE TESTING.
Context & Analysis
On Dec 4, 2025, Department of Health and Human Services obligated $294,894.6 to PROMEGA CORPORATION for geneprint(r) 24 system, 400rxn kits for patient care testing.. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in FITCHBURG, WI. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325413 — related awards are listed below.
Contractor Information
Similar Awards
ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND
SIRO DIAGNOSTICS, INC.
$28.3M
ZSU CEPHEID GENEXPERT REQUIRES GROUP B REAGENTS KITS
CEPHEID
$3.7M
MSU CEPHEID TESTING KITS
CEPHEID
$1.2M
TPSU CEPHEID TESTING KITS
CEPHEID
$756,310
DELIVERY ORDER FOR REAGENTS AND CONSUMABLES FOR GOVENRMENT-OWNED ROCHE BENCHMARK ULTRA IMMUNOSTAINERS IN SUPPORT OF NIH/NCI/CCR/CLINICAL IMMUNOHISTOCHEMISTRY LABORATORY OF THE LABORATORY OF PATHOLOGY (LP)
ROCHE DIAGNOSTICS CORPORATION
$600,000
Stay Updated
Get notified about new opportunities matching your interests.